Percutaneous ablation of renal cell carcinoma. Where do we stand now? Sanja Stojanović, Spasić Aleksandar
|
|
- Eileen Beasley
- 5 years ago
- Views:
Transcription
1 Percutaneous ablation of renal cell carcinoma Where do we stand now? Sanja Stojanović, Spasić Aleksandar Clinical Center of Vojvodina / Center for Radiology Novi Sad Serbia
2 Renal cell carcinoma approximately less than 4 % of all new cancers in the western world The detection rate has been increasing in recent years Incidental finding
3 Which RCCs are we speaking about T1 T2: T3: T4: T1a: tumour confined to kidney, <4 cm T1b:tumourconfined to kidney,>4 cm but <7 cm
4 4 cm Treated area deployment of thermal energy
5 ELECTRODES
6 How to enlarge area of ablation
7 Hyperthermic ablation in depth understanding of the mechanism Thermal conduction from small heating zone Mechanism of celullar injury Central zone necrosis Periphery - sublethal Immune activation antigen presentation Chu CF, Dupuy D. Thermal ablation of tumours: biological mechanisms and advances in therapy. Cancer; 2014.
8 Cryoablation Liquefied gases (Argon) -20 to -40 C 1cm beyond the lesion Mechanism of cellular injury Even better immune activation - sometime inactivation Chu CF, Dupuy D. Thermal ablation of tumours: biological mechanisms and advances in therapy. Cancer; 2014.
9 Immunomodulation Often too weak to completely overcome disease Synergy with ablation - imunnoadjuvants Chu CF, Dupuy D. Thermal ablation of tumours: biological mechanisms and advances in therapy. Cancer; 2014.
10 Partial Nephrectomy Thermal Ablation
11
12 PATIENT SELECTION BIAS
13
14 - Patients that are not fit or are not willing to undergo surgical treatment - Active surveilance onlyfor those patients with ct1a RCC that cannot undergo percutaneous treatment
15 Partial Nephrectomy Thermal Ablation Armamentorium Lethal mechanism Immunomodulation Pathology Image guidance Effect of procedure
16 RF CRYO Cornelis FH et al. A Comparative Study of Ablation Boundary Sharpness AfterPercutaneousRadiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys. CIRSE; 2017.
17 Biopsy-mandatory Percentage Survival Fuhrman grading 18G needle Multiple subtypes of RCC Byopsy Pathology Abla on Comparisson with other modalities (PN) Disease Specific Survival (months) Metastases T1a 7% RCC 3-4cm 11% Further therapy by oncologists
18 Patient selection Small renal mass: T1a; T1b? Comorbid conditions Advanced age Single kidney Multiple masses(vhl)
19 Ideal lesionfor RF Small ( 3cm/4cm?) Posterior Exophytic Far away from critical structures
20 Multiple tumours Proximity of colon Proximity of spleen Proximity of hilus - pyeloureter -vascular
21
22
23
24 Image guidance CT US inferior control ablation induced artifacts MRI robust equipement availibility
25
26
27 colon Hydrodissection RCC to push away structures in close proximity infusion of liquid One needle Two needles
28 Complications Hemorrhage(thinner or thicker needles) Subcapsular Retroperitoneal Hematuria Central locations Cryoablation better tolerated by pyelocaliceal wall Pyeloperfusion (cold or warmed liquids)
29 Atwell TD et al. PercutaneousAblation ofrenal Masses Measuring3.0 cm and Smaller: ComparativeLocal Control and Complications After Radiofrequency Ablation and Cryoablation. AJR; 2013.
30 Prediction of complications Radius Exophytic/endophytic % Major Complication Nearness to collecting system Anterior/posterior R.E.N.A.L. Score Location relative to polar lines Schmit GD et al. Usefulness of R.E.N.A.L. NephrometryScoring System forpredicting Outcomes and Complications of PercutaneousAblation of 751 Renal Tumors. J.Urology; 2013.
31 10-12 % Local Failure Radius Months Post Treatment Exophytic/endophytic Nearness to collecting system Anterior/posterior Location relative to polar lines Prediction of local success
32 Approach Electrodeposition Skin landmark 90 angle
33 RF or PN
34
35 Single kidney / multiple RCC - Renal reserve -Partial nephrectomy or thermal ablation? - Control of complications
36 T1a lesion 26mm lesion Position 1 Position 2 After ablation
37 Control sectional imaging -4 weeks after ablation rest of the ablated tumour -after 3, 6, 9 or 12 months institution protocol -US: liquid complica ons (Hydronephrosis, Collec ons...) CT/MRI 3 months 1 year 2 years
38 Follow up Early follow up imaging not recommended unless complication (bleeding..) suspected Late follow up -no consensus on chosen modality Comparation to preoperative imaging Lack of enhancement Decrease in size of the ablative zone Peripheral enhancement (usualy disappears after 6 months) Recurrent tumor versus inflammatory changes --New baseline after 6 months
39 Conclusion - Guidelines - T1a(b) tumours - Biopsy - Pursuing excellence in technique and understanding of lethal mechanisms - Learning curve
40 Thank you for your attention!
Is renal cryoablation becoming an effective alternative to partial nephrectomy?
Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University
More informationWhat is the role of partial nephrectomy in the context of active surveillance and renal ablation?
What is the role of partial nephrectomy in the context of active surveillance and renal ablation? Dogu Teber Department of Urology University Hospital Heidelberg Coming from Heidelberg obligates to speak
More informationKilling Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?
Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts
More informationLess is more: Merit of Non-Surgical Management of Kidney Cancer
Less is more: Merit of Non-Surgical Management of Kidney Cancer S A T U R D A Y, A U G U S T 2 0 G H A S S A N E L - H A D D A D, MD A S S I S TA N T M E M B E R, VA S C U L A R A N D I N T E R V E N T
More informationPatient Selection for Ablative Therapies. Adrian D Joyce Leeds UK
Patient Selection for Ablative Adrian D Joyce Leeds UK Therapy Renal Cell Ca USA: 30,000 new cases annually >12,000 deaths RCC accounts for 3% of all adult malignancy 40% of patients will die from their
More informationablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine
Sorveglianza attiva e trattamenti ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Risk of mortality in RCC patients Kutikov A. et al. J Clin Oncol 2010;
More informationONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE
ONCOLOGIC PERCUTANEOUS INTERVENTION: 2015 UPDATE HANH VU NGHIEM, MD OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE ONCOLOGIC PERCUTANEOUS IMAGE GUIDED TUMOR ABLATION Evolving, growing and increasingly
More informationMahrad Paymani, MD Lake Medical Imaging
Mahrad Paymani, MD Lake Medical Imaging Background: My name is Mahrad Paymani. I am an Interventional and General Radiologist. I attended four years of college (at UNC Greensboro), four years of medical
More informationUsefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors
Usefulness of R.E.N.A.L. Nephrometry Scoring System for Predicting Outcomes and Complications of Percutaneous Ablation of 751 Renal Tumors Grant D. Schmit,* R. Houston Thompson, Anil N. Kurup, Adam J.
More informationFreeze, Fry or Cut. Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018
Freeze, Fry or Cut Jennifer A. Linehan, MD Associate Professor Urologic Oncology John Wayne Cancer Institute 2/9/2018 Disclosures Consultant for UroGen Pharma. REDEFINING WHAT SURGEONS SEE Bay Area-based
More informationAdvances of Thermal Ablation. Dr Chandan J Das. MD,DNB, MNAMS Associate Professor of Radiology, All India Institute of Medical Sciences, New-Delhi.
Advances of Thermal Ablation Dr Chandan J Das. MD,DNB, MNAMS Associate Professor of Radiology, All India Institute of Medical Sciences, New-Delhi. Nothing to disclose Disclaimer Goals of Minimally Invasive
More informationGUIDELINES ON RENAL CELL CARCINOMA
GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists
More informationRF Ablation: indication, technique and imaging follow-up
RF Ablation: indication, technique and imaging follow-up Trongtum Tongdee, M.D. Radiology Department, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand Objective Basic knowledge
More informationQuestions to ask before you have a kidney removed for kidney cancer
Questions to ask before you have a kidney removed for kidney cancer Updated March 11, 2011 If you have a small kidney cancer (less than 7 cm.), you have several treatment options available to you. These
More informationFocal Ablative Therapies for Kidney Cancer
Focal Ablative Therapies for Kidney Cancer Robert J. Hamilton, MD, MPH, FRCSC Staff Urologist, Princess Margaret Cancer Centre Assistant Prof., Dept. of Surgery (Urology), University of Toronto ICUC January
More informationGuidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer
Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group
More informationRENAL CANCER. Dr. Giandomenico Roviello. Oncologia Medica Ospedale San Donato Arezzo
RENAL CANCER Dr. Giandomenico Roviello Oncologia Medica Ospedale San Donato Arezzo Abstracts Abstract Number: 433. Cryoablation of ct1 renal masses in the healthy patient: Early outcomes from Mayo Clinic.
More informationSmall Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas
Small Renal Mass Guidelines Clif Vestal, MD USMD Arlington, Texas Evaluation/Diagnosis 1. Obtain high quality, multiphase, cross-sectional abdominal imaging to optimally characterize/stage the renal mass.
More informationVincenzo Ficarra 1,2,3. Associate Editor BJU International
Partial Nephrectomy for RCC Vincenzo Ficarra 1,2,3 1 Director Department of Urology University of Udine, Italy 2 Associate Editor BJU International 3 Scientific Director OLV Robotic Surgery Institute,
More informationIndications For Partial
Indications For Partial Nephrectomy Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship in Urology Department of Urology The University of Texas
More informationStereotactic Body Radiation Therapy and Radiofrequency Ablation 2014 Masters of Minimally Invasive Surgery
Stereotactic Body Radiation Therapy and Radiofrequency Ablation 2014 Masters of Minimally Invasive Surgery Matthew Hartwig, M.D. Duke Cancer Institute Case Presentation I: Patient ER 74 y/o male with A1A
More informationHow I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1
HOW I DO IT How I do it: percutaneous radiofrequency ablation (RFA) Igor Sorokin, MD 1 Murthy Chamarthy, MD, 2 Jeffrey A. Cadeddu, MD 1,2 1 Department of Urology, UT Southwestern Medical Center, Dallas,
More informationRadiofrequency Ablation of Liver Tumors
Radiofrequency Ablation of Liver Tumors Michael M. Awad, Michael A. Choti Indications and Contraindications Indications Unresectable malignant tumors of the liver (e.g., hepatocellular carcinoma, colorectal
More informationFreezing and Frying Renal Cancers:
Freezing and Frying Renal Cancers: An Imaging Menu for Radiologists to Understand Intra- and Post-Procedural Imaging Findings after Renal Tumor Ablation Heidi Coy BS, Michael Douek MD, Steven Raman MD
More informationCanadian Guidelines for Management of the Small Renal Mass (SRM)
Canadian Guidelines for Management of the Small Renal Mass (SRM) Michael A.S. Jewett*, Ricardo Rendon, Louis Lacombe, Pierre I. Karakiewicz, Simon Tanguay, Wes Kassouf, Mike Leveridge, Ilias Cagiannos,
More informationPresentation of Cases /Audience Voting/Panel/Discussion
Presentation of Cases /Audience Voting/Panel/Discussion JJ Patard Tim O Brien Ninth European International Kidney Cancer Symposium Dublin 25-26 April 2014 Clinical case 1 63 years old women Medical past
More informationRenal biopsy is mandatory for every small renal mass
Renal biopsy is mandatory for every small renal mass Ben Challacombe Consultant Urologist The Urology Centre Guy s and St. Thomas Hospital NHS Foundation Trust Oncocytoma High Risk Partial converted to
More informationRenal Mass Biopsy Should be Used for Most SRM - PRO
Renal Mass Biopsy Should be Used for Most SRM - PRO Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center GU Cancer Lead, Cancer Care Ontario Associate Professor,
More informationHyperechoic renal masses
Hyperechoic renal masses Jean-Yves Meuwly, MD Department of Diagnostic and Interventional Radiology, University Hospital Lausanne, Switzerland Department of Diagnostic and Interventional Radiology Renal
More informationUrinary tract embolization
Beograd, 14.10.2012 Urinary tract embolization asist. Peter Popovič, MD, MSc Head of abdominal radiology department, Institute of Radiology, UMC Ljubljana Embolization Who and when procedure: local/general
More informationGuidelines on Renal Cell
Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma
More informationRenal Mass Biopsy: Needed Now More than Ever
Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,
More informationPercutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes
Percutaneous Renal Cryoablation After Partial Nephrectomy: Technical Feasibility, Complications and Outcomes Ryan M. Hegg, Grant D. Schmit,* Stephen A. Boorjian, Robert J. McDonald, A. Nicholas Kurup,
More informationKIDNEY HEALTH. Kidney Masses and Localized Kidney Tumors: A Patient Guide
KIDNEY HEALTH Kidney Masses and Localized Kidney Tumors: A Patient Guide Table of Contents Kidney & Adrenal Health Committee Renal Mass Committee.... 2 Patient Story.... 3 Introduction: I have a kidney
More informationDamian Dupuy, MD. Image Guided Intervention (IGI) Studies 10:25 11:05 AM
Damian Dupuy, MD Image Guided Intervention (IGI) Studies 10:25 11:05 AM Image Guided Intervention (IGI) Studies Damian E. Dupuy, M.D., FACR Professor of Diagnostic Imaging The Warren Alpert Medical School
More informationRadiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer
Radiofrequency ablation combined with conventional radiotherapy: a treatment option for patients with medically inoperable lung cancer Poster No.: C-0654 Congress: ECR 2011 Type: Scientific Paper Authors:
More informationJohn Fitzpatrick Memorial Lecture. John Fitzpatrick Memorial lecture
John Fitzpatrick Memorial Lecture John Fitzpatrick Memorial Lecture John M Fitzpatrick, 1948 2014 Head of Research at the Irish Cancer Society Professor of Surgery and Consultant Urologist at the Mater
More informationoth percutaneous radiofrequency ablation (RFA) and cryoablation have shown favorable local tumor
Vascular and Interventional Radiology Original Research Atwell et al. Radiofrequency Ablation and Cryoablation of Small Renal Masses Vascular and Interventional Radiology Original Research Thomas D. Atwell
More informationLiver Directed Therapy for Hepatocellular Carcinoma
Liver Directed Therapy for Hepatocellular Carcinoma Anil K Pillai MD, FRCR, Associate Professor, Department of Radiology UT Houston Health Science Center, Houston, TX, United States. Hepatocellular cancer
More informationMinimal invasive treatment of small renal masses
Minimal invasive treatment of small renal masses Financial disclosure: Advisor and proctor: BTG Ole Graumann, MD, PhD, Associate Professor Dep. of Radiology, Odense University Hospital Head of Radiology
More informationCombined Percutaneous Radiofrequency Ablation and Ethanol Injection of Renal Tumours: Midterm Results
european urology 52 (2007) 777 784 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Combined Percutaneous Radiofrequency Ablation and Ethanol Injection of Renal
More informationUS-Guided Radiofrequency Ablation of Hepatic Focal Lesions
US-Guided Radiofrequency Ablation of Hepatic Focal Lesions Poster No.: C-2219 Congress: ECR 2011 Type: Scientific Exhibit Authors: D. Armario Bel, A. PLA, F. TERREL, X. Serres; BARCELONA/ES Keywords: Neoplasia,
More information9/8/2014. Cryoablation & RF Ablation for Renal Tumors, Challenges and Pearls for Success. RFA and Cryoablation for Renal Tumors
9/8/2014 Cryoablation & RF Ablation for Renal Tumors, Challenges and Pearls for Success Debra A. Gervais, MD Division Chief, Abdominal Imaging, Massachusetts General Hospital Associate Professor, Harvard
More informationRadiofrequency ablation of kidney tumours and lesions: A review of the literature
Review Article Radiofrequency ablation of kidney tumours and lesions: A review of the literature Anthony Kodzo-Grey Venyo * Venyo AKG. Radiofrequency ablation of kidney tumours and lesions: A review of
More informationInterventional Oncology Patient Awareness
Interventional Oncology Patient Awareness Interventional Radiology: your minimally invasive alternative www.cirse.org Cardiovascular and Interventional Radiological Society of Europe Cardiovascular and
More informationRAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara
RAPN in T1b Renal Masses? A. Mottrie G. Denaeyer, P. Schatteman, G. Novara Department of Urology O.L.V. Clinic Aalst OLV Vattikuti Robotic Surgery Institute Aalst Belgium Guidelines on Renal Cell Carcinoma
More informationNaif H. Alsaikhan, MD Noushin Vahdat, MD. University of California in San Diego VA San Diego Healthcare System
Naif H. Alsaikhan, MD Noushin Vahdat, MD University of California in San Diego VA San Diego Healthcare System Goals Describe the morphologic parameters that urologists and interventional radiologists need
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous cryotherapy for renal cancer Treating kidney tumours by freezing
More informationComplex case Presentations
Complex case Presentations Case Presentations April 2016 Lisa M Pickering Case presentations: chromophobe renal carcinoma 60 year old man. ECOG PS 0 No significant comorbodities August 2009: L radical
More informationMultiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer
Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer RadioGraphics 2018; 38:437 449 Pritesh Patel, MD Melvy S. Mathew, MD Igor Trilisky, MD Aytekin Oto, MD, MBA Jeffrey S. Klein,
More informationAUA Guidelines Renal Mass and Localized Kidney Cancer
AUA Guidelines Renal Mass and Localized Kidney Cancer Steven C. Campbell, MD, PhD Chair AUA Guidelines Panel Professor Surgery, Vice Chair, Program Director Department of Urology Glickman Urological and
More informationManagement of Colorectal Liver Metastases
Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver
More informationDirectness Consistency Precision Reporting Bias
responsible for the accuracy and presentation of the material. Supplemental Table. Strength of evidence for primary. Key Outcomes* Studies (N) Study limitations Directness Consistency Precision Reporting
More informationCanadian Urological Association guidelines for followup of patients after treatment of nonmetastatic
Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,
More informationGUIDELINES ON RENAL CELL CANCER
20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance
More informationThe Incidental Renal Mass in the Primary Care Setting
The Incidental Renal Mass in the Primary Care Setting Adele M. Caruso, MSN, CRNP Adult Nurse Practitioner The Perelman School of Medicine at the University of Pennsylvania Abstract There are approximately
More informationStaging & Current treatment of HCC
Staging & Current treatment of HCC Dr.: Adel El Badrawy Badrawy; ; M.D. Staging & Current ttt of HCC Early stage HCC is typically silent. HCC is often advanced at first manifestation. The selective ttt
More informationSex: 女 Age: 51 Occupation: 無 Admission date:92/07/22
Sex: 女 Age: 51 Occupation: 無 Admission date:92/07/22 Chief complaint Unknown fever for one month Hand tremor and left huge renal tumor was noted Present illness Suffered from fever for one month, hand
More informationPercutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases
Chin J Radiol 2005; 30: 153-158 153 Percutaneous Ultrasound-guided Radiofrequency Ablation of Colorectal Liver Metastases YI-YOU CHIOU YI-HONG CHOU JEN-HUEY CHIANG HSIN-KAI WANG CHENG-YEN CHANG Department
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016?
ACTIVE SURVEILLANCE FOR RENAL MASSES: Where are we in 2016? Phillip M. Pierorazio, MD Assistant Professor of Urology and Oncology Brady Urological Institute Sidney Kimmel Cancer Center Johns Hopkins Hospital
More informationRFA of Tumors of the Lung: How and Why. Radiofrequency Ablation. Radiofrequency Ablation. RFA of pulmonary metastases. Radiofrequency Ablation of Lung
RFA of Tumors of the Lung: How and Why Radiofrequency Ablation of Lung Ernest Scalzetti MD SUNY Upstate Medical University Syracuse NY FDA WARNING: Off-label use of a medical device Radiofrequency Ablation
More informationRADIOFREQUENCY ABLATION
RADIOFREQUENCY ABLATION ELIZABETH DAVID M D FRCPC VASCULAR A ND INTERVENTIONAL RADIOLOGIST SUNNYBROOK HEALTH SCIENCES CENTRE GIST GASTROINTESTINAL STROMAL TUMORS Stromal or mesenchymal neoplasms affecting
More informationRadiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience
Radiofrequency Ablation Treatment for Renal Cell Carcinoma: Early Clinical Experience Seong-Hoon Park, MD 1 Seong Kuk Yoon, MD 1 Jin Han Cho, MD 1 Jong Young Oh, MD 1 Kyung Jin Nam, MD 1 Hee-Jin Kwon,
More informationManchester Cancer. Guidelines for the management of renal cancer
Guidelines for the management of renal cancer Approved by the urology pathway board September 2014 To be reviewed September 2016 Renal Cancer Guidelines 1. Introduction 1.1 Kidney cancer accounts for 3%
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationRENAL Nephrometry Scoring System: The Radiologist s Perspective
Genitourinary Imaging Clinical Perspective Parsons et al. Nephrometry Score Genitourinary Imaging Clinical Perspective Rosaleen B. Parsons 1 Daniel Canter 2 Alexander Kutikov 3 Robert G. Uzzo 3 Parsons
More informationCELON POWER SYSTEM FOR TUMOR ABLATION Bipolar and Multipolar RFA
1 CELON POWER SYSTEM FOR TUMOR ABLATION Bipolar and Multipolar RFA SAFE, EFFECTIVE AND UNIQUE Bipolar and multipolar radiofrequency ablation (RFA) with the CELON Power System allows an effective treatment
More informationPercutaneous ablation: indications, techniques and results
Percutaneous ablation: indications, techniques and results Giovan Giuseppe Di Costanzo Dipartimento dei Trapianti UOSC Epatologia AORN A Cardarelli - Napoli Treatment algorithm EASL, EORTC guidelines HCC
More informationMicrowave ablation of lung tumors
Microwave ablation of lung tumors Poster No.: C-2490 Congress: ECR 2012 Type: Scientific Exhibit Authors: G. Carrafiello 1, A. M. Ierardi 1, E. Macchi 1, N. Lucchina 1, V. Molinelli 1, E. Duka 1, C. Pellegrino
More informationChallenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs
Management options in VHL associated RCCs Challenges in RCC surgery JJ PATARD, MD, PhD Paris XI University Observation, Radical nephrectomy, Renal parenchymal sparing surgery, Open, laparoscopic, robotic
More informationCurrently, radiofrequency (RF) ablation is the most commonly
Diagn Interv Radiol 2010; 16:90 95 Turkish Society of Radiology 2010 INTERVENTIONAL RADIOLOGY REVIEW Percutaneous cryoablation techniques and clinical applications Servet Tatlı, Murat Acar, Kemal Tuncalı,
More informationJames Cassuto, MS IV. Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology
Student: Attendings: Department: James Cassuto, MS IV Grigory Rozenblit, MD Shekher Maddineni, MD Samuel McCabe, MD Vascular and Interventional Radiology Chief Complaint & HPI 61 year old female who is
More informationSurgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting Renal Cell Carcinoma
Case Study TheScientificWorldJOURNAL (2009) 9, 5 9 TSW Urology ISSN 1537-744X; DOI 10.1100/tsw.2009.6 Surgically Discovered Xanthogranulomatous Pyelonephritis Invading Inferior Vena Cava with Coexisting
More informationOver 35,000 new cases of renal
DEBRA A. GERVAIS, MD Director of Abdominal Interventional Radiology Assistant Professor of Radiology RONALD S. ARELLANO, MD Director of Abdominal Intervention Clinic Operations Instructor of Radiology
More informationThe Surgical Management of RCC
The Surgical Management of RCC From Robson to Radiofrequency Ablation Tony Finelli, MD, MSc, FRCSC University Health Network University of Toronto Background Renal cell carcinoma (RCC) is 9 th most common
More informationRenal Masses in Patients with Known Extrarenal Primary Primary Cancer Primary Primary n Met Mets s RCC Beni L mphoma Lung Breast Others
The Importance of Stuart G. Silverman, MD, FACR Professor of Radiology Harvard ard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston, MA The Importance of
More informationCT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes
Original Article Genitourinary Imaging http://dx.doi.org/10.3348/kjr.2016.17.5.763 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2016;17(5):763-770 CT-Guided Radiofrequency Ablation of T1a Renal Cell
More informationSalvage surgery after energy ablation for renal masses
Salvage surgery after energy ablation for renal masses Jose A. Karam, Christopher G. Wood, Zachary R. Compton, Priya Rao*, Raghunandan Vikram, Kamran Ahrar and Surena F. Matin Departments of Urology, *Pathology,
More informationCase Report Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation of Renal Cell Carcinoma
Hindawi Publishing Corporation Case Reports in Urology Volume 2012, Article ID 390912, 5 pages doi:10.1155/2012/390912 Case Report Multimodality Fusion with MRI, CT, and Ultrasound Contrast for Ablation
More informationEUROPEAN UROLOGY 61 (2012)
EUROPEAN UROLOGY 61 (2012) 1156 1161 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Alvin C. Goh and Inderbir S. Gill on pp. 1162
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationMicrowave ablation of liver metastases to overcome radiofrequency ablation limits
Microwave ablation of liver metastases to overcome radiofrequency ablation limits Poster No.: C-2456 Congress: ECR 2012 Type: Scientific Exhibit Authors: G. Carrafiello 1, A. M. Ierardi 1, V. Molinelli
More informationUse of microwave ablation in the treatment of patients with multiple primary malignant tumors
Thoracic Cancer ISSN 1759-7706 CASE REPORT Use of microwave ablation in the treatment of patients with multiple primary malignant tumors Yue Han 1, Na Shao 2, Xiaoming Xi 3 & Xuezhi Hao 3 1 Department
More informationPartial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches
Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches Cary N Robertson MD FACS Associate Professor Division of Urology Associate Director Urologic Oncology Duke Cancer
More informationNew Energy Sources for Local Ablation Therapy. Jeong Kyong Lee, MD Ewha Womans University
New Energy Sources for Local Ablation Therapy Jeong Kyong Lee, MD Ewha Womans University New Energy Sources for Local Ablation Therapy Microwave Ablation Irreversible Electroporation Cryoablation Microwave
More informationDiagnosis and management of retroperitoneal sarcoma
SON Update 2017 Diagnosis and management of retroperitoneal sarcoma Andrea J MacNeill, MD MSc FRCSC Surgical Oncologist, BC Cancer Agency Vancouver 2 Histologic Subtypes of STS 3 RP Subtypes (n=684) Extremity
More informationThermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication
Avoidable Nerve Damage in Radiofrequency Ablation Interventional Radiology Technical Innovation Andreas Boss 1,2 Stephan Clasen 1 Markus Kuczyk 3 Aristotelis Anastasiadis 3 Diethard Schmidt 1 Claus D.
More informationThermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication
Avoidable Nerve Damage in Radiofrequency Ablation Interventional Radiology Technical Innovation Andreas Boss 1,2 Stephan Clasen 1 Markus Kuczyk 3 Aristotelis Anastasiadis 3 Diethard Schmidt 1 Claus D.
More informationSurgical Management of Renal Cancer. David Nicol Consultant Urologist
Surgical Management of Renal Cancer David Nicol Consultant Urologist Roles of Surgery 1. Curative intervention localised disease 2. Symptomatic control advanced disease 3. Augmentation of efficacy of systemic
More informationGeneral summary GENERAL SUMMARY
General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with
More informationPercutaneous Radiofrequency Ablation of Lung Malignant Tumours: Survival, disease progression and complication rates
Percutaneous Radiofrequency Ablation of Lung Malignant Tumours: Survival, disease progression and complication rates Poster No.: C-2576 Congress: ECR 2012 Type: Authors: Keywords: DOI: Scientific Exhibit
More informationMultidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute
Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 20 April, Antalya, Turkey RCC European Union 60.000 new diagnoses/year 26.000 Cancer related deaths
More informationSurgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute
Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 23 March 2012, Sao Paulo, Brazil Surgery of RCC Locally confined (small) renal tumours Locally advanced disease Metastatic
More informationCRYOABLATION OF SOLID TUMORS
Status Active Medical and Behavioral Health Policy Section: Surgery Policy Number: IV-05 Effective Date: 06/16/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should
More informationState-of-the-art minimally invasive interventions for liver tumors
William Lo, HMS MD/PhD candidate, MS III Gillian Lieberman, MD State-of-the-art minimally invasive interventions for liver tumors William Lo, HMS MD/PhD candidate, MS III Gillian Lieberman, MD
More informationProstate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS
Prostate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS Current State of Prostate Focal Therapy Patient Selection Focal Ablation Technology and Technique Follow-up/ Surveillance after
More informationStereotactic ablative body radiotherapy for renal cancer
1 EVIDENCE SUMMARY REPORT Stereotactic ablative body radiotherapy for renal cancer Questions to be addressed 1. What is the clinical effectiveness of stereotactic ablative body radiotherapy for inoperable
More informationCryoablation in the Management of Early Stage Breast Cancer
13 th Annual Pacific Northwest Breast and Gynecologic Care Conference Cryoablation in the Management of Early Stage Breast Cancer Dennis R. Holmes, M.D., Inc. Int. Director, Margie Peterson Breast Center
More informationFalse-Positive Tumor Enhancement After Cryoablation of Renal Cell Carcinoma: A Prospective Study
Genitourinary Imaging Original Research Takaki et al. False-Positive Tumor Enhancement on MRI After Cryoablation of RCCs Genitourinary Imaging Original Research Haruyuki Takaki 1 Atsuhiro Nakatsuka 1 Francois
More information